{"id":"https://openalex.org/W4362547992","doi":"https://doi.org/10.1158/2326-6066.22546646.v1","title":"Supplementary Data from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors","display_name":"Supplementary Data from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362547992","doi":"https://doi.org/10.1158/2326-6066.22546646.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.22546646.v1","doi":"https://doi.org/10.1158/2326-6066.22546646.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22546646.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.22546646.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076370806","display_name":"Jeroen Slaats","orcid":"https://orcid.org/0000-0003-3800-3138","observed_orcids":["https://orcid.org/0000-0003-3800-3138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeroen Slaats","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3800-3138","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077005500","display_name":"Esther Wagena","orcid":"https://orcid.org/0000-0002-6722-1495","observed_orcids":["https://orcid.org/0000-0002-6722-1495"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esther Wagena","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6722-1495","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083969796","display_name":"Daan Smits","orcid":"https://orcid.org/0000-0002-3090-4321","observed_orcids":["https://orcid.org/0000-0002-3090-4321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daan Smits","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3090-4321","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006146706","display_name":"Annemarie A. Berends","orcid":"https://orcid.org/0000-0001-5124-8821","observed_orcids":["https://orcid.org/0000-0001-5124-8821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annemarie A. Berends","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5124-8821","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031426836","display_name":"Ella Peters","orcid":"https://orcid.org/0000-0002-3622-8475","observed_orcids":["https://orcid.org/0000-0002-3622-8475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ella Peters","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3622-8475","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082642221","display_name":"Gert\u2010Jan Bakker","orcid":"https://orcid.org/0000-0003-3602-0014","observed_orcids":["https://orcid.org/0000-0003-3602-0014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gert-Jan Bakker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3602-0014","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067213239","display_name":"Merijn van Erp","orcid":"https://orcid.org/0000-0002-9642-9789","observed_orcids":["https://orcid.org/0000-0002-9642-9789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Merijn van Erp","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9642-9789","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019346530","display_name":"Bettina Weigelin","orcid":"https://orcid.org/0000-0003-4460-3113","observed_orcids":["https://orcid.org/0000-0003-4460-3113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bettina Weigelin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4460-3113","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015323424","display_name":"Gosse J. Adema","orcid":"https://orcid.org/0000-0002-6750-1665","observed_orcids":["https://orcid.org/0000-0002-6750-1665"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gosse J. Adema","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6750-1665","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5026527299","display_name":"Peter Friedl","orcid":"https://orcid.org/0000-0002-0119-4041","observed_orcids":["https://orcid.org/0000-0002-0119-4041"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Friedl","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0119-4041","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.9079999923706055},{"id":"https://openalex.org/keywords/receptor-antagonism","display_name":"receptor antagonism","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9330000281333923},{"id":"https://openalex.org/keywords/antitumor-cytotoxicity","display_name":"tumor cytotoxicity","score":0.7590000033378601},{"id":"https://openalex.org/keywords/tumor-metabolism","display_name":"cancer metabolism","score":0.8330000042915344},{"id":"https://openalex.org/keywords/metabolic-perturbation","display_name":"metabolic perturbation","score":0.6520000100135803},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6129999756813049},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.382999986410141}],"concepts":[{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.915306568145752},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.8526442050933838},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.7794351577758789},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.5659866333007812},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5168669819831848},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.5165159106254578},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5073019862174988},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5045665502548218},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4461299180984497},{"id":"https://openalex.org/C2778491162","wikidata":"https://www.wikidata.org/wiki/Q3063865","display_name":"Adenosine A2A receptor","level":5,"score":0.43278759717941284},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32232677936553955},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24571934342384338},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20784428715705872},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.05136033892631531}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2326-6066.22546646.v1","doi":"https://doi.org/10.1158/2326-6066.22546646.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22546646.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22546646","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/media/Supplementary_Data_from_Adenosine_A2a_Receptor_Antagonism_Restores_Additive_Cytotoxicity_by_Cytotoxic_T_Cells_in_Metabolically_Perturbed_Tumors/22546646","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.22546646.v1","doi":"https://doi.org/10.1158/2326-6066.22546646.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22546646.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362547410","https://openalex.org/W4297100972","https://openalex.org/W4206077930","https://openalex.org/W2804340288","https://openalex.org/W2885253947","https://openalex.org/W2954721151","https://openalex.org/W4361240204","https://openalex.org/W2036018074","https://openalex.org/W1980760876","https://openalex.org/W2077703512"],"abstract_inverted_index":{"Supplementary":[0],"Data":[1],"from":[2],"Adenosine":[3],"A2a":[4],"Receptor":[5],"Antagonism":[6],"Restores":[7],"Additive":[8],"Cytotoxicity":[9],"by":[10],"Cytotoxic":[11],"T":[12],"Cells":[13],"in":[14],"Metabolically":[15],"Perturbed":[16],"Tumors":[17]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-06T00:00:00"}